Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer

NCT01898117

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • MCA Alkmaar, Netherlands
  • Noordwest Ziekenhuis Groep Alkmaar, Netherlands
  • ZGT Almelo, Netherlands
  • Meander Medisch Centrum Amersfoort, Netherlands
View all 49 locations
View Trial Details
Active, Not Recruiting

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

NCT05032092

Conditions
Locally Advanced Carcinoma, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • University Hospital Salzburg, Department of Internal Medicine III Salzburg, State of Salzburg, Austria
  • Medical University of Innsbruck, Department of Hematology and Oncology Innsbruck, Tyrol, Austria
  • Ordensklinikum Linz Linz, Upper Austria, Austria
  • Landeskrankenhaus Feldkirch, Department of Internal Medicine II Feldkirch, Vorarlberg, Austria
View Trial Details
Active, Not Recruiting

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

NCT06784648

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +27 more
Locations
  • Charité - Universitatsmedizin Berlin Berlin, Germany
  • University Hospital Essen Essen, Germany
  • University Hospital Heidelberg Heidelberg, Germany
  • University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg and Clinical Cooperation Unit Dermato-Oncology(G300) German Cancer Research Center(DKFZ) Mannheim, Germany
View Trial Details
Active, Not Recruiting

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

NCT03539536

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of South Alabama /ID# 212939 Mobile, Alabama, United States
  • Mayo Clinic Arizona /ID# 218550 Phoenix, Arizona, United States
  • Highlands Oncology Group, PA /ID# 215600 Springdale, Arkansas, United States
  • University of California, Los Angeles /ID# 203219 Los Angeles, California, United States
View all 252 locations
View Trial Details

Related conditions